The Auxiliary Effects of Low-Molecular-Weight Fucoidan in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy Before Surgery: A Double-Blind, Randomized, Placebo-Controlled Study

The Auxiliary Effects of Low-Molecular-Weight Fucoidan in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy Before Surgery: A Double-Blind, Randomized, Placebo-Controlled Study

Patients with cancer use low-molecular-weight fucoidan (LMF) as a supplement to therapy. However, most studies of LMF are in vitro or conducted using animals. Concurrent chemoradiotherapy (CCRT) is the gold standard for locally advanced rectal cancer (LARC). This study investigated the quality of li...

Full description

Bibliographic Details
Main Authors: Hsiang-Lin Tsai MD, PhD, Yung-Sung Yeh MD, Po-Jung Chen MD, Yu-Tang Chang MD, Yen-Cheng Chen MD, Wei-Chih Su MD, Tsung-Kun Chang MD, Ching-Wen Huang MD, PhD, Jaw-Yuan Wang MD, PhD
Format: Article
Language:English
Published: SAGE Publishing 2023-10-01
Series:Integrative Cancer Therapies
Online Access:https://doi.org/10.1177/15347354231187153

Similar Items

Similar Items